Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Genitourinary 1

Conditions

Smoking Cessation 1Prostatic Neoplasms 1Lung Neoplasms 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × sulforaphane × Clear all
NCT03232138 2024-12-17

Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers

University of Pittsburgh

Phase 2 Completed
43 enrolled 19 charts
Thoracic

Lung Neoplasms, Smoking Cessation

NCT01228084 2017-04-28

Sulforaphane in Treating Patients With Recurrent Prostate Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
20 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡